Observational study on the safety and performance of BWI medical devices for treating heart rhythm disorders
Official title: An Observational Post-marketing Study for Evaluation of Ongoing Safety and Effectiveness of Catheter Mapping and Ablation Using Commercially Approved BWI Medical Devices for the Treatment of Patients With Cardiac Arrhythmias
Run by Biosense Webster, Inc. · NCT04750798 · Data updated 2026-11-12
This study looks at how safe and effective certain heart devices are for people with heart rhythm disorders during their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 8000 (estimated) |
| Sponsor | Biosense Webster, Inc. Industry-sponsored |
| Locations | 47 sites (Graz and 46 other locations) |
| Status | Recruiting |
| Started | February 22, 2021 |
| Main results expected | December 31, 2036 |
| Study ends | December 31, 2037 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT04750798 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with paroxysmal or persistent Atrial Fibrillation, supraventricular tachycardia, or ventricular tachycardia who are scheduled for an ablation procedure.
✕Probably not a fit
Patients currently involved in other interventional clinical trials or with a life expectancy of less than 12 months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to collect clinical data on the safety and performance of Biosense Webster Inc. medical devices during standard cardiac arrhythmia mapping and ablation procedures. Participants diagnosed with specific types of arrhythmias will be monitored as they undergo treatment using these commercially approved devices. The data gathered will help confirm the ongoing safety and effectiveness of these devices in real-world clinical settings and contribute to the overall understanding of their use in managing cardiac arrhythmias.
Why it matters
Potential benefit: If successful, this study could enhance the safety and effectiveness of treatments for patients with cardiac arrhythmias.
How similar studies have gone: Other studies have shown success with similar observational approaches in evaluating medical devices, indicating a potential for valuable insights from this study.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria * Diagnosed with paroxysmal or persistent Atrial Fibrillation (AF) or supraventricular tachycardia (SVT) or ventricular tachycardia (VT) and scheduled to undergo an ablation procedure for management of their arrhythmia with a per-protocol defined BW therapeutic catheter * Able and willing to comply with all pre, post and follow-up testing and requirements as per hospital standard of care * Signed patient informed consent form (ICF) as applicable per local regulation Exclusion criteria: * Currently participating in an interventional (drug, device, biologic) clinical trial * Life expectancy of less than 12-months * Presenting any contraindication for the use of BWI commercially approved medical devices, as indicated in the respective user manuals
Where it's running
-
Medical University of Graz
Graz, Austria Recruiting -
Ordensklinikum Linz GMBH
Linz, Austria Recruiting -
Universitätsklinikum Wiener Neustadt
Wiener Neustadt, Austria Recruiting -
OLV Aalst
Aalst, Belgium Recruiting -
AZ Sint-Jan Brugge
Bruges, Belgium Recruiting -
CHU Saint-Pierre
Brussels, Belgium Recruiting
Show 41 more locations
-
UZ Antwerp
Edegem, Belgium Recruiting -
Maria Middelares
Ghent, Belgium Recruiting -
Jessa Hospital
Hasselt, Belgium Recruiting -
UZ Brussels
Jette, Belgium Recruiting -
ASBL CHU HELORA Hôpital de La Louvière site Jolimont
La Louvière, Belgium Recruiting -
Aarhus University Hospital
Aarhus, Denmark Recruiting -
Rigshospitalet
Copenhagen, Denmark Recruiting -
CHU de Clermont-Ferrand
Clermont-Ferrand, France Recruiting -
Les Hospices Civils de Lyon
Lyon, France Recruiting -
Hôpital Saint Joseph de Marseille
Marseille, France Recruiting -
Institut Mutualiste Montsouris
Paris, France Recruiting -
CHU de Rennes
Rennes, France Recruiting -
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, France Recruiting -
Centre Hospitalier Universitaire de Bordeaux
Talence, France Recruiting -
Rhön-Klinikum Campus Bad Neustadt
Bad Neustadt an der Saale, Germany Recruiting -
Herz- und Diabeteszentrum NRW, University Hospital of the Ruhr University Bochum
Bad Oeynhausen, Germany Recruiting -
Segeberger Kliniken
Bad Segeberg, Germany Recruiting -
Oberlausitz-Kliniken
Bautzen, Germany Recruiting -
Alfried Krupp Hospital
Essen, Germany Recruiting -
Justus-Liebig-University Giessen
Giessen, Germany Recruiting -
Asklepios Klinik Altona
Hamburg, Germany Recruiting -
German Heart Centre Munich
Munich, Germany Recruiting -
Semmelweis University
Budapest, Hungary Recruiting -
Mater Private Heart and Vascular Centre
Dublin, Ireland Recruiting -
Shaare Zedek Medical Center
Jerusalem, Israel Recruiting -
Ospedale Generale Regionale "F. Miulli"
Acquaviva delle Fonti, Italy Recruiting -
A.O. Universitaria Delle Marche
Ancona, Italy Recruiting -
IRCCS Policlinico San Donato
Milan, Italy Recruiting -
Clinica Mediterranea
Naples, Italy Recruiting -
Clinical Trial Center Maastricht
Maastricht, Netherlands Recruiting -
Erasmus University Medical Center
Rotterdam, Netherlands Recruiting -
Haukeland University Hospital
Bergen, Norway Recruiting -
Hospital de Santa Cruz
Carnaxide, Portugal Recruiting -
Sahlgrenska University Hospital
Gothenburg, Sweden Recruiting -
INSELSPITAL Universitätsspital Bern
Bern, Switzerland Recruiting -
Glenfield Hospital
Leicester, United Kingdom Recruiting -
St George's Hospital
London, United Kingdom Recruiting -
Royal Brompton Hospital
London, United Kingdom Recruiting -
Cardioangiologisches Centrum Bethanien (CCB)
Frankfurt, Germany Completed -
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel Completed -
St. Bartholomew's Hospital
London, United Kingdom Completed
Study contacts
- Study coordinator: Nathalie Macours
- Email: nmacours1@its.jnj.com
- Phone: +32 479 97 05 05
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can fluoroscopy plus TTE guidance improve leadless pacemaker placement accuracy
This study tests whether using transthoracic echocardiography (TTE) during leadless pacemaker placement improves accuracy and safety compared with standard fluoroscopy.
-
Dual Energy ThermoCool SmartTouch SF Catheter with TRUPULSE Generator for Ventricular Arrhythmias
This study tests a special catheter and generator setup to treat ventricular arrhythmias and checks that the procedure can be done safely following a specific workflow.
-
Volta AI software in real-world AF ablation
A real-world observational study will test the latest Volta AF-Xplorer II AI software during atrial fibrillation ablation to see how safe and effective it is over 24 months.
-
Pacing decisions guided by risk for pacing-induced heart muscle weakness
This study tests a risk score to predict pacing-induced cardiomyopathy in adults getting heart rhythm devices, to tailor pacing choices.
-
Heart assessment to check repeat-stroke risk in people with atrial fibrillation
This project will test whether detailed heart examinations can find which people with atrial fibrillation who just had an ischemic stroke are at high risk of having another stroke.
-
Sensor-guided exercise program for people with atrial fibrillation
This program will test whether a Fitbit-based, personalized exercise plan can reduce symptoms and episode burden in people with paroxysmal atrial fibrillation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.